Publications by authors named "Kayo Horibe"
Diabetes Res Clin Pract
April 2022
Article Synopsis
- - The study aimed to see the effects of the SGLT2 inhibitor dapagliflozin on body composition and amino acid metabolism in overweight patients being treated for diabetes.
- - After 24 weeks, the dapagliflozin group experienced a greater reduction in body mass (about 1.72 kg) compared to the standard treatment group, primarily by losing fat while maintaining fat-free mass.
- - Although there were minor changes in amino acid levels, only serine levels significantly decreased in the dapagliflozin group, with some positive links between branched-chain amino acids and body composition changes observed in this group.
